Methotrexate causes a change in intestinal 5-hydroxytryptamine metabolism in rats

Abstract

The effects of methotrexate on 5-hydroxytryptamine (5-HT) metabolism in the intestinal tissue of rats were investigated during the delayed phase after a single administration. Rats were i.p. injected with methotrexate or with saline as a control, and kaolin and food intakes were measured by an automatic monitoring apparatus. At 96h after administration, dissected-out ileal tissue was frozen rapidly in liquid nitrogen for further analysis or fixed for immunohistochemical staining. Methotrexate at a dose of 50mg/kg caused a time-dependent increase in kaolin intake lasting up to 72h after administration, which returned to the control level at 96h after administration. This dose of methotrexate caused a gradual decrease in body weight, food intake, and water intake lasting up to 72h, which approached the control level at 96h. Methotrexate caused pathologic changes, including a moderate inflammatory response in the ileal tissue and an increase in the number of l-tryptophan hydroxylase (TPH)-expressing cells in the ileal mucosa. Methotrexate also caused a significant increase in 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) content and in TPH1 mRNA expression in the ileal tissues. It had no significant effects on mRNA expression of serotonin transporter, COX-1, or COX-2 or on myeloperoxidase activity. This study demonstrated, for the first time, that methotrexate caused a change in the ileal 5-HT metabolism associated with hyperplasia of mucosal enterochromaffin cells.